8.03
price up icon0.37%   0.03
after-market Handel nachbörslich: 8.03
loading
Schlusskurs vom Vortag:
$8.00
Offen:
$8.1
24-Stunden-Volumen:
31,118
Relative Volume:
0.70
Marktkapitalisierung:
$417.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.32M
KGV:
-11.69
EPS:
-0.687
Netto-Cashflow:
$-36.14M
1W Leistung:
-0.86%
1M Leistung:
+23.73%
6M Leistung:
-31.25%
1J Leistung:
-2.78%
1-Tages-Spanne:
Value
$7.7342
$8.305
1-Wochen-Bereich:
Value
$7.7342
$9.02
52-Wochen-Spanne:
Value
$5.05
$14.99

Gh Research Plc Stock (GHRS) Company Profile

Name
Firmenname
Gh Research Plc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
49
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GHRS's Discussions on Twitter

Gh Research Plc Stock (GHRS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-08-16 Eingeleitet H.C. Wainwright Buy
2022-06-16 Eingeleitet ROTH Capital Buy

Gh Research Plc Aktie (GHRS) Neueste Nachrichten

pulisher
03:05 AM

GH Research (NASDAQ:GHRS) Stock Price Up 0.6%Time to Buy? - MarketBeat

03:05 AM
pulisher
Nov 04, 2024

GH Research (NASDAQ:GHRS) Shares Up 0.7%Still a Buy? - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

abrdn plc Raises Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

(GHRS) On The My Stocks Page - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

GH Research (NASDAQ:GHRS) Shares Up 2.2%Time to Buy? - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Standard Chartered Bank Ghana PLC (SCB.gh) Q32024 Interim Report - AfricanFinancials

Nov 01, 2024
pulisher
Oct 31, 2024

GH Research PLC (NASDAQ:GHRS) Sees Significant Growth in Short Interest - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

GH Research (NASDAQ:GHRS) Shares Down 1%What's Next? - MarketBeat

Oct 31, 2024
pulisher
Oct 30, 2024

GH Research (NASDAQ:GHRS) Shares Up 2.8%Here's What Happened - MarketBeat

Oct 30, 2024
pulisher
Oct 29, 2024

GH Research (NASDAQ:GHRS) Trading Down 0.1%Here's Why - MarketBeat

Oct 29, 2024
pulisher
Oct 29, 2024

Acromegaly Market Innovations Investigated by Size, Share, Trends And Outlook Report 2024-2033 - WhaTech

Oct 29, 2024
pulisher
Oct 29, 2024

Psychedelic Drugs Industry Size, Growth Opportunities - openPR

Oct 29, 2024
pulisher
Oct 28, 2024

GH Research (NASDAQ:GHRS) Trading 3.3% HigherHere's Why - MarketBeat

Oct 28, 2024
pulisher
Oct 22, 2024

How To Trade (GHRS) - Stock Traders Daily

Oct 22, 2024
pulisher
Oct 22, 2024

Stanbic Bank facilitates GH¢200m bond issuance for Kasapreko PLC - Graphic Online

Oct 22, 2024
pulisher
Oct 21, 2024

GGBL announces dividend of GH¢0.022 per share for shareholders - Myjoyonline

Oct 21, 2024
pulisher
Oct 11, 2024

Objective long/short (GHRS) Report - Stock Traders Daily

Oct 11, 2024
pulisher
Oct 03, 2024

Tullow Oil Plc (TLW.gh) HY2024 Presentation - AfricanFinancials

Oct 03, 2024
pulisher
Sep 30, 2024

When (GHRS) Moves Investors should Listen - Stock Traders Daily

Sep 30, 2024
pulisher
Sep 28, 2024

Mackenzie Financial Corp Has $148.34 Million Holdings in Ferguson plc (NASDAQ:FERG) - Defense World

Sep 28, 2024
pulisher
Sep 28, 2024

GH Research PLC (NASDAQ:GHRS) Shares Bought by Lynx1 Capital Management LP - Defense World

Sep 28, 2024
pulisher
Sep 27, 2024

Lynx1 Capital Management LP Has $46.25 Million Holdings in GH Research PLC (NASDAQ:GHRS) - MarketBeat

Sep 27, 2024
pulisher
Sep 27, 2024

Hsbc Holdings PLC Has $2.01 Million Stake in Guardant Health, Inc. (NASDAQ:GH) - Defense World

Sep 27, 2024
pulisher
Sep 23, 2024

ACTH and GH Function Tests Market – Industry Forecast and Growth Potential - Elektrotransports.lv

Sep 23, 2024
pulisher
Sep 21, 2024

Magic mushroom market set to go gangbusters, Irish researcher says - Mugglehead

Sep 21, 2024
pulisher
Sep 19, 2024

(GHRS) Investment Report - Stock Traders Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Guardant Health (NASDAQ:GH) Shares Down 3.5% - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Guardant Health, Inc. (GH) Stock Price, News, Quote & History - Yahoo Finance

Sep 19, 2024
pulisher
Sep 16, 2024

GH Research Engages Investors at Healthcare Conference - TipRanks

Sep 16, 2024
pulisher
Sep 09, 2024

GH Research to Engage at Global Investment Conference - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

GH Research PLC (NASDAQ:GHRS) to Post FY2024 Earnings of ($0.75) Per Share, HC Wainwright Forecasts - Defense World

Sep 09, 2024
pulisher
Sep 09, 2024

GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Sep 09, 2024
pulisher
Sep 09, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

Sep 09, 2024
pulisher
Sep 09, 2024

HC Wainwright Weighs in on GH Research PLC's FY2024 Earnings (NASDAQ:GHRS) - MarketBeat

Sep 09, 2024
pulisher
Sep 07, 2024

Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials - MSN

Sep 07, 2024
pulisher
Sep 06, 2024

GH Research (NASDAQ:GHRS) Receives Buy Rating from HC Wainwright - Defense World

Sep 06, 2024
pulisher
Sep 05, 2024

GH Research (NASDAQ:GHRS) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Sep 05, 2024
pulisher
Sep 05, 2024

GH Research (NASDAQ:GHRS) Receives Market Outperform Rating from JMP Securities - Defense World

Sep 05, 2024
pulisher
Sep 04, 2024

GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates - Yahoo Finance UK

Sep 04, 2024
pulisher
Sep 04, 2024

JMP Securities Reaffirms Market Outperform Rating for GH Research (NASDAQ:GHRS) - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

GH Research (NASDAQ:GHRS) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Sep 04, 2024
pulisher
Sep 04, 2024

Trend Tracker for (GHRS) - Stock Traders Daily

Sep 04, 2024
pulisher
Sep 03, 2024

GH Research names new CEO amid clinical trials - Investing.com India

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research to Connect at Global Healthcare Conference - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research (NASDAQ:GHRS) Shares Gap Down to $10.50 - MarketBeat

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research names new CEO amid clinical trials By Investing.com - Investing.com Canada

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research’s losses persist as it tries to lift FDA hold for GH001 - Green Market Report

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - Yahoo Finance UK

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research Appoints New CEO, Advances Trials - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

GH Research appoints Velichka Valcheva to CEO - TipRanks

Sep 03, 2024
pulisher
Aug 30, 2024

Gemini Therapeutics (NASDAQ:GMTX) versus GH Research (NASDAQ:GHRS) Head-To-Head Review - Defense World

Aug 30, 2024

Finanzdaten der Gh Research Plc-Aktie (GHRS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):